CAS 112665-43-7
:Seratrodast
Description:
Seratrodast, with the CAS number 112665-43-7, is a chemical compound primarily recognized for its role as a selective antagonist of the leukotriene receptor. It is classified as a therapeutic agent, particularly in the context of respiratory diseases such as asthma and allergic rhinitis. The compound functions by inhibiting the action of leukotrienes, which are inflammatory mediators that contribute to bronchoconstriction and airway inflammation. Seratrodast is typically administered orally and has been studied for its potential to improve respiratory function and reduce symptoms associated with allergic conditions. Its pharmacological profile includes anti-inflammatory properties, making it a candidate for managing chronic inflammatory diseases. The compound's safety and efficacy have been evaluated in clinical settings, contributing to its understanding as a therapeutic option. As with any medication, potential side effects and contraindications should be considered, and it is essential to consult healthcare professionals for appropriate use.
Formula:C22H26O4
InChI:InChI=1/C6H9N3O2/c1-9-5(7)4(3-8-9)6(10)11-2/h3H,7H2,1-2H3
InChI key:InChIKey=ZBVKEHDGYSLCCC-UHFFFAOYSA-N
SMILES:C(CCCCCC(O)=O)(C1=C(C)C(=O)C(C)=C(C)C1=O)C2=CC=CC=C2
Synonyms:- (+-)-2,4,5-Trimethyl-3,6-dioxo-zeta-phenyl-1,4-cyclohexadiene-1-heptanoic acid
- (+-)-7-(3,5,6-Trimethyl-1,4-benzoquinon-2-yl)-7-phenylheptanoic acid
- (±)-2,4,5-Trimethyl-3,6-dioxo-ζ-phenyl-1,4-cyclohexadiene-1-heptanoic acid
- 7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dienyl)-7-Phenylheptanoic Acid
- 7-Phenyl-7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dien-1-Yl)Heptanoic Acid
- A 73001
- Aa-2414
- Abbott 73001
- Abt 001
- Benzeneheptanoic acid, zeta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-, (+-)-
- Benzeneheptanoic acid, ζ-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-
- Bronica
- Ccris 8939
- Seratodrast
- Seratrodast [USAN:INN]
- Unii-4U58Jm421N
- methyl 5-amino-1-methyl-1H-pyrazole-4-carboxylate
- ζ-(2,4,5-Trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid
- Serabenast
- beta-(2,4,5-trimethyl-3,6-dioxo-1,4-cyclohexadien-1-yl)-bezeneheptanoicaci
- (±)-ζ-2,4,5-Trimethyl-3,6-dioxo-1,4-cyclohexadien-1-y1)benzeneheptanoic acid
- Bronic
- 7-(3,5,6-trimethy1-1,4-benzoquinon-2-y1)-7-phenylheptanoic acid
- 5-(2,4,5-trimethyl-3,6,-dioxo-1,4-cyclohexadien-1-yl)benzeneheptanoic acid
- 7-phenyl-7-(2,4,5-trimethyl-3,6-dioxo-1-cyclohexa-1,4-dienyl)heptanoic acid
- See more synonyms
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 10 products.
Seratrodast
CAS:Seratrodast (ABT-001), a TXA2 receptor blocker, treats asthma; first approved in Japan, 1997.Formula:C22H26O4Purity:99.54% - 99.69%Color and Shape:Pale Orange SolidMolecular weight:354.447-Phenyl-7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dien-1-Yl)Heptanoic Acid
CAS:7-Phenyl-7-(2,4,5-Trimethyl-3,6-Dioxocyclohexa-1,4-Dien-1-Yl)Heptanoic AcidPurity:98%Molecular weight:354.44g/molSeratrodast
CAS:Formula:C22H26O4Purity:>98.0%(T)(HPLC)Color and Shape:Light yellow to Brown powder to crystalMolecular weight:354.45Seratrodast
CAS:<p>Thromboxane A2 antagonist; anti-asthmatic</p>Formula:C22H26O4Purity:Min. 95%Color and Shape:Yellow PowderMolecular weight:354.44 g/molSeratrodast - Bio-X ™
CAS:<p>Seratrodast is a thromboxane receptor antagonist that is used to treat asthma. However, this drug does not affect thrombus formation as other thromboxane synthase inhibitors do such as ozagrel.</p>Formula:C22H26O4Purity:Min. 95%Color and Shape:PowderMolecular weight:354.44 g/molSeratrodast
CAS:Controlled Product<p>Applications Thromboxane A2-receptor antagonist. Antiasthmatic.<br>References Hussein, Z., et al.: Clin. Pharmacol. Ther., 55, 441 (1994),<br></p>Formula:C22H26O4Color and Shape:NeatMolecular weight:354.44







